Horizon Therapeutics (HZNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2012 | 12-2011 | 12-2010 | 12-2009 | 12-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -87,794 | -113,265 | -27,065 | -20,500 | -27,899 |
| Depreciation Amortization | 8,278 | 76,528 | 2,973 | 845 | 388 |
| Accounts receivable | -1,087 | -1,817 | -516 | N/A | N/A |
| Accounts payable and accrued liabilities | -2,209 | 5,643 | -1,137 | 137 | 269 |
| Other Working Capital | -3,980 | -8,356 | 2,031 | 1,342 | 2,871 |
| Other Operating Activity | 10,151 | -273 | -13,818 | -216 | 400 |
| Operating Cash Flow | $-76,641 | $-41,540 | $-37,532 | $-18,392 | $-23,971 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,336 | -1,604 | -714 | -357 | -786 |
| Net Acquisitions | N/A | N/A | 6,489 | N/A | N/A |
| Other Investing Activity | -50 | -550 | -200 | 0 | 0 |
| Investing Cash Flow | $-1,386 | $-2,154 | $5,575 | $-357 | $-786 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 55,578 | 23,417 | 20,058 | 9,000 | 18,000 |
| Debt Repayment | -19,788 | -13,067 | -10,981 | -4,181 | N/A |
| Common Stock Issued | 128,518 | 44,802 | N/A | 1 | N/A |
| Other Financing Activity | 0 | 0 | 20,683 | 7,022 | 0 |
| Financing Cash Flow | $164,308 | $55,152 | $29,760 | $11,842 | $18,000 |
| Exchange Rate Effect | -160 | 1,124 | 421 | N/A | N/A |
| Beginning Cash Position | 17,966 | 5,384 | 7,160 | 14,067 | 20,824 |
| End Cash Position | 104,087 | 17,966 | 5,384 | 7,160 | 14,067 |
| Net Cash Flow | $86,121 | $12,582 | $-1,776 | $-6,907 | $-6,757 |
| Free Cash Flow | |||||
| Operating Cash Flow | -76,641 | -41,540 | -37,532 | -18,392 | -23,971 |
| Capital Expenditure | -1,336 | -1,604 | -714 | -617 | -786 |
| Free Cash Flow | -77,977 | -43,144 | -38,246 | -19,009 | -24,757 |